AURA
Aura Biosciences, Inc.
Recent 8-K filings for AURA
Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.
-
May 11, 2026 20:05 UTC earnings item 2.02item 8.01item 9.01
Aura Q1 net loss $33.7M; Phase 3 CoMpass enrollment mid-2026; new CEO appointed
source · AURA on sec.gov